222 related articles for article (PubMed ID: 10372270)
1. Medical therapy for inflammatory bowel disease.
Stein RB; Hanauer SB
Gastroenterol Clin North Am; 1999 Jun; 28(2):297-321. PubMed ID: 10372270
[TBL] [Abstract][Full Text] [Related]
2. Current therapy of inflammatory bowel disease in children.
Rufo PA; Bousvaros A
Paediatr Drugs; 2006; 8(5):279-302. PubMed ID: 17037946
[TBL] [Abstract][Full Text] [Related]
3. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
[TBL] [Abstract][Full Text] [Related]
4. The state of the art in the management of inflammatory bowel disease.
Hanauer SB; Present DH
Rev Gastroenterol Disord; 2003; 3(2):81-92. PubMed ID: 12776005
[TBL] [Abstract][Full Text] [Related]
5. Current medical therapy for inflammatory bowel disease.
Bonner GF
South Med J; 1996 Jun; 89(6):556-66. PubMed ID: 8638193
[TBL] [Abstract][Full Text] [Related]
6. [Medical therapy of inflammatory bowel diseases: ulcerative colitis].
Lakatos L; Lakatos PL
Orv Hetil; 2007 Jun; 148(25):1163-70. PubMed ID: 17573252
[TBL] [Abstract][Full Text] [Related]
7. Newer treatments for inflammatory bowel disease.
Stotland BR; Lichtenstein GR
Prim Care; 1996 Sep; 23(3):577-608. PubMed ID: 8888346
[TBL] [Abstract][Full Text] [Related]
8. Medical therapy of inflammatory bowel disease for the 21st century.
Robinson M
Eur J Surg Suppl; 1998; (582):90-8. PubMed ID: 10029372
[TBL] [Abstract][Full Text] [Related]
9. [Classical medications in the treatment of inflammatory bowel diseases].
Duvnjak M; Bilić A; Barsić N; Tomasić V; Stojsavljević S
Acta Med Croatica; 2013 Apr; 67(2):111-24. PubMed ID: 24471294
[TBL] [Abstract][Full Text] [Related]
10. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease: current therapeutic options.
Domènech E
Digestion; 2006; 73 Suppl 1():67-76. PubMed ID: 16498254
[TBL] [Abstract][Full Text] [Related]
12. Insights in immunomodulatory therapies for ulcerative colitis and Crohn's disease.
Nguyen GC; Harris ML; Dassopoulos T
Curr Gastroenterol Rep; 2006 Dec; 8(6):499-505. PubMed ID: 17105689
[TBL] [Abstract][Full Text] [Related]
13. Medical therapy of specific clinical presentations.
Michetti P; Peppercorn MA
Gastroenterol Clin North Am; 1999 Jun; 28(2):353-70, viii. PubMed ID: 10372272
[TBL] [Abstract][Full Text] [Related]
14. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
[TBL] [Abstract][Full Text] [Related]
15. Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease.
Panaccione R; Rutgeerts P; Sandborn WJ; Feagan B; Schreiber S; Ghosh S
Aliment Pharmacol Ther; 2008 Sep; 28(6):674-88. PubMed ID: 18532990
[TBL] [Abstract][Full Text] [Related]
16. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
Hanauer SB; Stathopoulos G
Drug Saf; 1991; 6(3):192-219. PubMed ID: 1676590
[TBL] [Abstract][Full Text] [Related]
17. [The use of methotrexate in an inflammatory bowel diseases based on the review of the current literature].
Klimczak K; Łykowska-Szuber L; Krela-Kaźmierczak I; Eder P; Szymczak A; Stawczyk-Eder K; Linke K
Wiad Lek; 2016; 69(2 Pt 2):262-6. PubMed ID: 27487545
[TBL] [Abstract][Full Text] [Related]
18. Classical and recent advances in the treatment of inflammatory bowel diseases.
Sales-Campos H; Basso PJ; Alves VB; Fonseca MT; Bonfá G; Nardini V; Cardoso CR
Braz J Med Biol Res; 2015 Feb; 48(2):96-107. PubMed ID: 25466162
[TBL] [Abstract][Full Text] [Related]
19. Medical management of patients with difficult-to-treat inflammatory bowel disease.
van Hogezand RA
Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
[TBL] [Abstract][Full Text] [Related]
20. Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
Blumenstein I; Herrmann E; Filmann N; Zosel C; Tacke W; Bock H; Dignass A; Hartmann F; Zeuzem S; Stein J; Schröder O
J Crohns Colitis; 2011 Jun; 5(3):203-10. PubMed ID: 21575882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]